Iguana Healthcare Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Iguana Healthcare Management’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-75,000	Closed	-$518K	–	82
2017 Q1	$518K	Buy	+75,000	New	+$586K	0.26%	64
2016 Q3	–	Sell	-100,000	Closed	-$1.41M	–	104
2016 Q2	$1.41M	Hold	100,000	–	–	0.57%	55
2016 Q1	$1.4M	Sell	100,000 -50,000	-33%	-$733K	0.51%	51
2015 Q4	$3.06M	Buy	150,000 +25,000	+20%	+$386K	1.01%	27
2015 Q3	$1.64M	Sell	125,000 -25,000	-17%	-$415K	0.65%	44
2015 Q2	$2.3M	Buy	+150,000	New	+$2.88M	0.73%	43

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Iguana Healthcare Management's AGTC Position: Q2 2017 in Review

Iguana Healthcare Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2017, closing a stake of 75,000 shares — an estimated $518K sold.

Iguana Healthcare Management first reported a position in AGTC in Q2 2015 and held it in 6 quarters. The position peaked at $3.06M in Q4 2015. 77 funds tracked by Wall St. Rank hold AGTC as of Q2 2017.

Iguana Healthcare Management reported no remaining Applied Genetic Technologies Corporation position as of Q2 2017 after selling out during the quarter.
Iguana Healthcare Management sold 75,000 Applied Genetic Technologies Corporation shares in Q2 2017, an estimated $518K.
Iguana Healthcare Management first reported a position in Applied Genetic Technologies Corporation in Q2 2015 and held it in 6 quarters.
Iguana Healthcare Management's Applied Genetic Technologies Corporation position peaked at $3.06M in Q4 2015.
77 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2017.

Based on Iguana Healthcare Management's 13F filing for Q2 2017, filed 14 Aug 2017.